<DOC>
	<DOCNO>NCT00338130</DOCNO>
	<brief_summary>The primary purpose study compare efficacy AZD6244 ( ARRY-142886 ) temozolomide patient advanced melanoma</brief_summary>
	<brief_title>Randomised Study Compare Efficacy AZD6244 v TMZ</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Diagnosed late stage malignant melanoma Aged 18 Female patient must postmenopausal negative urine pregnancy test premenopausal Any previous radiotherapy chemotherapy ( palliative radiotherapy acceptable ) Participation trial investigational product within previous 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Phase II</keyword>
	<keyword>AZD6244</keyword>
	<keyword>temozolomide</keyword>
</DOC>